A path or a new road in laboratory diagnostics? Biological mass spectrometry: Facts and perspectives

Gábor Elek, Károly Lapis

Research output: Contribution to journalReview article

6 Citations (Scopus)


Proteins in tissues and biofluids and their many attributes define the proteome. Proteome can be directly correlated to known diseases and histological regions allowing the diagnosis and monitoring of disease progression as well predicting the patient's response to specific treatments. Proteomics performs large-scale, high-throughput characterization of the human proteome, among others by biological mass spectrometry. Protein-chip technology coupled with bioinformatics is able to screen any protein source for putative disease biomarkers from a small sample volume (microliter range) by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS). This article discusses on a basic level both the technology and reliability of these methods.

Original languageEnglish
Pages (from-to)179-183
Number of pages5
JournalPathology and Oncology Research
Issue number3
Publication statusPublished - Jan 1 2006



  • Genomics
  • Mass spectrometry
  • Matrix
  • Protein biomarker
  • ProteinChip® system
  • Proteomics
  • Serum proteome
  • Tissue proteome

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Oncology
  • Cancer Research

Cite this